179 related articles for article (PubMed ID: 21161565)
1. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
[TBL] [Abstract][Full Text] [Related]
2. A new class of molecular targeted radioprotectors: GSK-3beta inhibitors.
Thotala DK; Geng L; Dickey AK; Hallahan DE; Yazlovitskaya EM
Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):557-65. PubMed ID: 20117291
[TBL] [Abstract][Full Text] [Related]
3. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells.
Tan J; Zhuang L; Leong HS; Iyer NG; Liu ET; Yu Q
Cancer Res; 2005 Oct; 65(19):9012-20. PubMed ID: 16204075
[TBL] [Abstract][Full Text] [Related]
6. Famotidine has a neuroprotective effect on MK-801 induced toxicity via the Akt/GSK-3β/β-catenin signaling pathway in the SH-SY5Y cell line.
Unal G; Dokumaci AH; Ozkartal CS; Yerer MB; Aricioglu F
Chem Biol Interact; 2019 Dec; 314():108823. PubMed ID: 31563592
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3beta in gastric cancer cells.
Thiel A; Heinonen M; Rintahaka J; Hallikainen T; Hemmes A; Dixon DA; Haglund C; Ristimäki A
J Biol Chem; 2006 Feb; 281(8):4564-9. PubMed ID: 16371352
[TBL] [Abstract][Full Text] [Related]
8. Specific glycogen synthase kinase-3 inhibition reduces neuroendocrine markers and suppresses neuroblastoma cell growth.
Carter YM; Kunnimalaiyaan S; Chen H; Gamblin TC; Kunnimalaiyaan M
Cancer Biol Ther; 2014 May; 15(5):510-5. PubMed ID: 24521712
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells.
Shen JY; Yi XX; Xiong NX; Wang HJ; Duan XW; Zhao HY
Neurosci Lett; 2011 Nov; 505(2):165-70. PubMed ID: 22019984
[TBL] [Abstract][Full Text] [Related]
10. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glycogen synthase kinase-3β by lithium chloride suppresses 6-hydroxydopamine-induced inflammatory response in primary cultured astrocytes.
Wang HM; Zhang T; Li Q; Huang JK; Chen RF; Sun XJ
Neurochem Int; 2013 Nov; 63(5):345-53. PubMed ID: 23871716
[TBL] [Abstract][Full Text] [Related]
12. A molecular study of pathways involved in the inhibition of cell proliferation in neuroblastoma B65 cells by the GSK-3 inhibitors lithium and SB-415286.
Pizarro JG; Folch J; Esparza JL; Jordan J; Pallàs M; Camins A
J Cell Mol Med; 2009 Sep; 13(9B):3906-17. PubMed ID: 18624766
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3β, NF-κB signaling, and tumorigenesis of human osteosarcoma.
Tang QL; Xie XB; Wang J; Chen Q; Han AJ; Zou CY; Yin JQ; Liu DW; Liang Y; Zhao ZQ; Yong BC; Zhang RH; Feng QS; Deng WG; Zhu XF; Zhou BP; Zeng YX; Shen JN; Kang T
J Natl Cancer Inst; 2012 May; 104(10):749-63. PubMed ID: 22534782
[TBL] [Abstract][Full Text] [Related]
14. Inactivation of glycogen synthase kinase-3beta contributes to brain-derived neutrophic factor/TrkB-induced resistance to chemotherapy in neuroblastoma cells.
Li Z; Tan F; Thiele CJ
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3113-21. PubMed ID: 18089706
[TBL] [Abstract][Full Text] [Related]
15. P27(Kip1), regulated by glycogen synthase kinase-3β, results in HMBA-induced differentiation of human gastric cancer cells.
Wei M; Wang Z; Yao H; Yang Z; Zhang Q; Liu B; Yu Y; Su L; Zhu Z; Gu Q
BMC Cancer; 2011 Mar; 11():109. PubMed ID: 21439087
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of glycogen synthase kinase-3 beta induces apoptosis and mitotic catastrophe by disrupting centrosome regulation in cancer cells.
Yoshino Y; Ishioka C
Sci Rep; 2015 Aug; 5():13249. PubMed ID: 26292722
[TBL] [Abstract][Full Text] [Related]
17. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3 acts upstream of ADP-ribosylation factor 6 and Rac1 to regulate epithelial cell migration.
Farooqui R; Zhu S; Fenteany G
Exp Cell Res; 2006 May; 312(9):1514-25. PubMed ID: 16529739
[TBL] [Abstract][Full Text] [Related]
19. Aberrant nuclear accumulation of glycogen synthase kinase-3beta in human pancreatic cancer: association with kinase activity and tumor dedifferentiation.
Ougolkov AV; Fernandez-Zapico ME; Bilim VN; Smyrk TC; Chari ST; Billadeau DD
Clin Cancer Res; 2006 Sep; 12(17):5074-81. PubMed ID: 16951223
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and biological evaluation of novel 4-azaindolyl-indolyl-maleimides as glycogen synthase kinase-3beta (GSK-3beta) inhibitors.
Ye Q; Xu G; Lv D; Cheng Z; Li J; Hu Y
Bioorg Med Chem; 2009 Jul; 17(13):4302-12. PubMed ID: 19481464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]